Abstract
SUMMARYDelirium is commonly misunderstood in patients with advanced disease. It can present as a hyperactive, hypoactive or fluctuating disorder. Antineoplastic agents and other drugs may cause delirium as can some drug interactions. Potential causes are described. Evaluation instruments that have been used for this symptom are described. Some open research questions are listed. A management algorithm, evidence tables, and drug therapy tables which include drug costs are presented.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have